SFE Investment Counsel Sells 145 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

SFE Investment Counsel reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,658 shares of the financial services provider’s stock after selling 145 shares during the quarter. SFE Investment Counsel’s holdings in iShares Biotechnology ETF were worth $361,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Moneta Group Investment Advisors LLC grew its stake in iShares Biotechnology ETF by 131,598.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after acquiring an additional 4,466,451 shares in the last quarter. JPMorgan Chase & Co. grew its stake in iShares Biotechnology ETF by 159.9% during the first quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock valued at $253,975,000 after acquiring an additional 1,209,700 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in iShares Biotechnology ETF by 49.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock valued at $204,332,000 after acquiring an additional 521,820 shares in the last quarter. Jane Street Group LLC grew its stake in iShares Biotechnology ETF by 5.4% during the fourth quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock valued at $131,625,000 after acquiring an additional 50,999 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $76,425,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $124.46 on Friday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16. The firm has a 50 day simple moving average of $135.29 and a two-hundred day simple moving average of $129.51.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.